# Kindeva Drug Delivery receives £33M investment for green inhaler manufacturing

Kindeva Drug Delivery received a grant from the U.K. Government's Life Sciences Innovation Manufacturing Fund, unlocking a £33 million investment to enhance manufacturing capability and capacity for next-generation green pressurized metered-dose inhalers at its Loughborough and Clitheroe sites.

- Type: Investment
- Announced: 2023-08-03
- Where: Loughborough and Clitheroe, U.K., United Kingdom
- Value: $41.8M (33.0M GBP)
- Status: announced
- Products: green pressurized metered-dose inhalers
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Kindeva Drug Delivery](https://endata.com/companies/46943.md)
- [U.K. Government](https://endata.com/companies/71828.md) (investor)

## Sources

- [businesswire.com](https://www.businesswire.com/news/home/20230803751029/en/U.K.-Government-Grant-Unlocks-%C2%A333M-Investment-With-Kindeva-Drug-Delivery-for-Greener-Inhaler-Future), 2023-08-03: "This joint investment of public and private funds creates myriad new opportunities for Kindeva colleagues within the U.K."
- [kindevadd.com](https://www.kindevadd.com/news/u-k-government-grant-unlocks-33m-investment-with-kindeva-drug-delivery-for-greener-inhaler-future/), 2023-08-03: "This joint investment of public and private funds creates myriad new opportunities for Kindeva colleagues within the U.K."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.